Spectrophotometric Determination of Some Angiotensin Converting Enzyme Inhibitors By Potassium Dichromate and Potassium Permanganate in Tablet Dosage Form

Potassium Permanganate ◽

Dosage Form ◽

Enzyme Inhibitors ◽

Potassium Dichromate ◽

Converting Enzyme ◽

Tablet Dosage

Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method

FEBS Letters ◽

10.1016/j.febslet.2007.06.048 ◽

2007 ◽

Vol 581 (18) ◽

pp. 3449-3454 ◽

Cited By ~ 10

Author(s):

Montserrat Andújar-Sánchez ◽

Vicente Jara-Pérez ◽

Ana Cámara-Artigas

Keyword(s):

Enzyme Inhibitors ◽

Binding Constants ◽

Converting Enzyme ◽

Displacement Method ◽

Thermodynamic Determination

An optimized fluoroenzymatic assay for the determination of angiotensin converting enzyme inhibitors in biological fluids

Journal of Pharmaceutical and Biomedical Analysis ◽

10.1016/0731-7085(88)80050-5 ◽

1988 ◽

Vol 6 (3) ◽

pp. 241-251 ◽

Cited By ~ 7

Author(s):

Kenneth Shepley ◽

Mario L. Rocci ◽

Herbert Patrick ◽

Parviz Mojaverian

Keyword(s):

Enzyme Inhibitors ◽

Biological Fluids ◽

Converting Enzyme ◽

An overview of chromatographic methods coupled with mass spectrometric detection for determination of angiotensin-converting enzyme inhibitors in biological material

Journal of Pharmaceutical and Biomedical Analysis ◽

10.1016/j.jpba.2007.03.018 ◽

2007 ◽

Vol 44 (2) ◽

pp. 356-367 ◽

Cited By ~ 11

Author(s):

Piotr J. Rudzki ◽

Katarzyna Buś ◽

Hanna Ksycińska ◽

Kamila Kobylińska

Keyword(s):

Biological Material ◽

Enzyme Inhibitors ◽

Mass Spectrometric ◽

Mass Spectrometric Detection ◽

Converting Enzyme ◽

Chromatographic Methods

Square wave voltammetric determination of the angiotensin-converting enzyme inhibitors cilazapril, quinapril and ramipril in pharmaceutical formulations

Il Farmaco ◽

10.1016/s0014-827x(03)00043-0 ◽

2003 ◽

Vol 58 (5) ◽

pp. 343-350 ◽

Cited By ~ 8

Author(s):

José Angel Prieto ◽

Rosa M. Jiménez ◽

Rosa M. Alonso

Keyword(s):

Enzyme Inhibitors ◽

Pharmaceutical Formulations ◽

Voltammetric Determination ◽

Converting Enzyme ◽

Square Wave

3644 Pleiotropic effect of angiotensin-converting enzyme inhibitors on MMP-9: a key enzyme in cardiac and vascular remodelling

European Heart Journal ◽

10.1016/s0195-668x(03)96228-2 ◽

2003 ◽

Vol 24 (5) ◽

pp. 711

Author(s):

D REINHARDT

Keyword(s):

Enzyme Inhibitors ◽

Pleiotropic Effect ◽

Converting Enzyme ◽

Vascular Remodelling ◽

Key Enzyme

Irbesartan Combined With Conventional Therapy, Including Angiotensin Converting Enzyme Inhibitors, in Heart Failure

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)84523-8 ◽

1998 ◽

Vol 31 (2) ◽

pp. 188A ◽

Cited By ~ 4

Author(s):

M Tonkon

Keyword(s):

Heart Failure ◽

Conventional Therapy ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Nephroprotective therapy with angiotensin converting enzyme inhibitors effect evaluation on the course of chronic kidney disease in children with urinary system congenital malformations

Nephrology (Saint-Petersburg) ◽

10.24884/1561-6274-2019-23-3-59-64 ◽

2019 ◽

Vol 23 (3) ◽

pp. 59-64

Author(s):

A. M. Mambetova ◽

A. M. Inarokova ◽

N. N. Shabalova ◽

D. V. Bizheva ◽

M. K. Mokaeva ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Congenital Malformations ◽

Enzyme Inhibitors ◽

Urinary System ◽

Converting Enzyme ◽

Effect Evaluation ◽

Reactions induced by angiotensin-converting enzyme inhibitors – etiopathogenic, clinical and therapeutic aspects

Alergologia ◽

10.26416/aler.1.1.2017.1240 ◽

2017 ◽

Vol 1 (1) ◽

Cited By ~ 2

Author(s):

Polliana Mihaela Leru

Keyword(s):

Enzyme Inhibitors ◽

Converting Enzyme ◽

Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin in chronic renal failure patients

MedPulse International Journal of Pharmacology ◽

10.26611/10101312 ◽

2020 ◽

Vol 13 (1) ◽

pp. 05-09

Author(s):

A Vinoth Kumar ◽

◽

P KalaiSelvi ◽

Keyword(s):

Renal Failure ◽

Chronic Renal Failure ◽

Enzyme Inhibitors ◽

Converting Enzyme ◽

Faculty Opinions recommendation of Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1090740.552962 ◽

2007 ◽

Author(s):

Carl Erik Mogensen

Keyword(s):

Kidney Disease ◽

Treatment Effects ◽

Enzyme Inhibitors ◽

Urinary Protein Excretion ◽

Converting Enzyme ◽

Protein Excretion ◽

Progression Risk